214 related articles for article (PubMed ID: 9531362)
1. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer.
Komaki R; Milas L; Ro JY; Fujii T; Perkins P; Allen P; Sikes CR; Mountain CF; Ordonez NG
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):787-96. PubMed ID: 9531362
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer.
Komaki R; Fujii T; Perkins P; Ro JY; Allen PK; Mason KA; Mountain CF; Milas L
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):601-5. PubMed ID: 8948344
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
4. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
Xu XY; Lin N; Li YM; Zhi C; Shen H
Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
[TBL] [Abstract][Full Text] [Related]
5. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of IGF1R expression in non-small-cell lung cancer.
Nakagawa M; Uramoto H; Oka S; Chikaishi Y; Iwanami T; Shimokawa H; So T; Hanagiri T; Tanaka F
Clin Lung Cancer; 2012 Mar; 13(2):136-42. PubMed ID: 22133293
[TBL] [Abstract][Full Text] [Related]
7. Evidence for apoptosis in non-small cell lung carcinoma. Relationship with cell kinetics and prognosis.
Matturri L; Colombo B; Lavezzi AM
Anal Quant Cytol Histol; 1999 Jun; 21(3):240-4. PubMed ID: 10560497
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of chromosomal imbalances in squamous cell carcinoma and adenocarcinoma of the lung.
Danner BC; Hellms T; Jung K; Gunawan B; Didilis V; Füzesi L; Schöndube FA
Ann Thorac Surg; 2011 Sep; 92(3):1038-43. PubMed ID: 21871296
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 expression and prognosis for smokers with resected stage I non-small cell lung cancer.
Haga Y; Hiroshima K; Iyoda A; Shibuya K; Shimamura F; Iizasa T; Fujisawa T; Ohwada H
Ann Thorac Surg; 2003 Jun; 75(6):1727-32; discussion 1732-3. PubMed ID: 12822607
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
[TBL] [Abstract][Full Text] [Related]
11. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors Greater Than 5 cm: Safety and Efficacy.
Woody NM; Stephans KL; Marwaha G; Djemil T; Videtic GM
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):325-31. PubMed ID: 25841625
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
14. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
[TBL] [Abstract][Full Text] [Related]
15. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.
Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D
J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640
[TBL] [Abstract][Full Text] [Related]
16. Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Di Carlo L; Semeraro A; Daddi G; Darwish S; Stocchi L; Tofanetti FR; Bellezza G; Sidoni A; Tognellini R; Crinò L; Tonato M
Tumori; 2008; 94(3):398-405. PubMed ID: 18705409
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of the DNA content of non-small cell lung cancer. Ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung.
Sahin AA; Ro JY; el-Naggar AK; Lee JS; Ayala AG; Teague K; Hong WK
Cancer; 1990 Feb; 65(3):530-7. PubMed ID: 2153432
[TBL] [Abstract][Full Text] [Related]
18. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of DNA content in stage I adenocarcinoma of the lung.
Roberts HL; Komaki R; Allen P; El-Naggar AK
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):573-8. PubMed ID: 9635704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]